Cutera, Inc. (CUTR) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Cutera, Inc. (NASDAQ:CUTR) have been given an average rating of “Hold” by the eight research firms that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $34.65.

Several equities analysts have commented on the stock. ValuEngine raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Thursday, November 1st. BidaskClub lowered shares of Cutera from a “buy” rating to a “hold” rating in a report on Thursday, September 20th. Stifel Nicolaus decreased their target price on shares of Cutera from $45.00 to $29.00 and set a “hold” rating on the stock in a report on Friday, October 5th. Zacks Investment Research lowered shares of Cutera from a “hold” rating to a “sell” rating in a report on Monday, August 13th. Finally, Stephens decreased their target price on shares of Cutera from $40.00 to $24.94 and set a “sell” rating on the stock in a report on Friday, October 5th.

CUTR stock traded up $0.18 during mid-day trading on Friday, hitting $20.50. The stock had a trading volume of 205,344 shares, compared to its average volume of 199,919. Cutera has a 52 week low of $19.11 and a 52 week high of $56.05. The firm has a market cap of $282.53 million, a P/E ratio of 26.62 and a beta of 0.83.

Cutera (NASDAQ:CUTR) last released its earnings results on Tuesday, November 6th. The medical device company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.03 by $0.08. Cutera had a net margin of 11.16% and a negative return on equity of 0.50%. The firm had revenue of $40.60 million for the quarter, compared to analyst estimates of $40.03 million. During the same period last year, the firm earned $0.42 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, equities research analysts forecast that Cutera will post -0.29 EPS for the current fiscal year.

Institutional investors have recently made changes to their positions in the stock. Piedmont Investment Advisors LLC bought a new stake in shares of Cutera during the 2nd quarter valued at approximately $128,000. SG Americas Securities LLC bought a new stake in shares of Cutera during the 2nd quarter valued at approximately $154,000. United Services Automobile Association bought a new stake in shares of Cutera during the 2nd quarter valued at approximately $208,000. Assenagon Asset Management S.A. bought a new stake in shares of Cutera during the 3rd quarter valued at approximately $263,000. Finally, MetLife Investment Advisors LLC grew its holdings in shares of Cutera by 54.6% during the 3rd quarter. MetLife Investment Advisors LLC now owns 10,424 shares of the medical device company’s stock valued at $339,000 after purchasing an additional 3,680 shares during the last quarter. 99.42% of the stock is currently owned by institutional investors.

About Cutera

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Further Reading: Fundamental Analysis and Choosing Stocks

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit